Literature DB >> 1658143

Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.

J Moreno1, D A Vignali, F Nadimi, S Fuchs, L Adorini, G J Hämmerling.   

Abstract

Class II MHC molecules on the surface of an APC present immunogenic peptides derived mainly from exogenous proteins to CD4+ T cells. During its transport to the cell surface, class II molecules intersect the endocytic pathway where they acquire peptides derived from endocytosed proteins. However, class II-restricted presentation of endogenously derived peptides can also occur. The current studies were undertaken to examine the ability of different types of APC to generate and present four different T cell determinants derived from an endogenous, nonsecreted, truncated form of hen-egg white lysozyme (HEL[1-80]-Kk). This was compared with the ability of these APC to generate the same determinants from exogenous HEL. All the peptides derived from endogenous HEL[1-80]-Kk tested, were presented by B cells to HEL-specific T cell hybridomas with an efficiency similar to presentation of the same determinants from exogenous HEL. In contrast, an I-Ak-bearing rat fibroblast was unable to generate the HEL peptide 25-43 from exogenous HEL, but could efficiently produce it from endogenous HEL[1-80]-Kk. The results indicate first, that peptides derived from an endogenous Ag can be presented by MHC class II molecules with an efficiency comparable to that of the presentation of the exogenous Ag. Second, that Ag-presenting B cells can generate the same repertoire of antigenic peptides from endogenous Ag as those generated from the exogenous protein. And third, that in contrast to B cells, certain "nonprofessional" APC can generate, from an endogenous protein, T cell determinants distinct from those generated after endocytosis of the exogenous protein. These results suggest that processing of exogenous and endogenous Ag by different APC take place in different intracellular compartments.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658143

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  15 in total

1.  Role of the major histocompatibility complex class II transmembrane region in antigen presentation and intracellular trafficking.

Authors:  Yelena A Barabanova; Hee-Kap Kang; Jinjong Myoung; Bongsu Kang; Gail A Bishop; Byung S Kim
Journal:  Immunology       Date:  2004-02       Impact factor: 7.397

Review 2.  Approaches toward peptide-based immunotherapy of autoimmune diseases.

Authors:  L Adorini; J C Guéry; S Trembleau
Journal:  Springer Semin Immunopathol       Date:  1992

Review 3.  Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways.

Authors:  Laurence C Eisenlohr; Nancy Luckashenak; Sebastien Apcher; Michael A Miller; Gomathinayagam Sinnathamby
Journal:  Immunol Res       Date:  2011-12       Impact factor: 2.829

4.  Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.

Authors:  S Sanderson; K Frauwirth; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

5.  Macrophages activated by Listeria monocytogenes induce organ-specific autoimmunity.

Authors:  K H Sonoda; G Matsuzaki; A Nomura; H Yamada; S Hamano; T Nakamura; A Mukasa; K Nomoto
Journal:  Immunology       Date:  1997-10       Impact factor: 7.397

6.  CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.

Authors:  F Rodriguez; S Harkins; J M Redwine; J M de Pereda; J L Whitton
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

7.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.

Authors:  J F Katz; C Stebbins; E Appella; A J Sant
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

8.  Assembly of HLA DR1 molecules translated in vitro: binding of peptide in the endoplasmic reticulum precludes association with invariant chain.

Authors:  M J Bijlmakers; P Benaroch; H L Ploegh
Journal:  EMBO J       Date:  1994-06-01       Impact factor: 11.598

9.  Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.

Authors:  R M Chicz; R G Urban; J C Gorga; D A Vignali; W S Lane; J L Strominger
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

10.  Experimental autoimmune peripheral neuritis induced in BALB/c mice by myelin basic protein-specific T cell clones.

Authors:  S Abromson-Leeman; R Bronson; M E Dorf
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.